- Home
- LIMN vs SWIM Comparison
LIMN vs SWIM Comparison
Compare LIMN & SWIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIMN
- SWIM
- Stock Information
- Founded
- LIMN 2018
- SWIM 1956
- Country
- LIMN United States
- SWIM United States
- Employees
- LIMN N/A
- SWIM N/A
- Industry
- LIMN
- SWIM Plastic Products
- Sector
- LIMN
- SWIM Industrials
- Exchange
- LIMN NYSE
- SWIM Nasdaq
- Market Cap
- LIMN 623.8M
- SWIM 678.4M
- IPO Year
- LIMN N/A
- SWIM 2021
- Fundamental
- Price
- LIMN $16.60
- SWIM $6.52
- Analyst Decision
- LIMN
- SWIM Hold
- Analyst Count
- LIMN 0
- SWIM 4
- Target Price
- LIMN N/A
- SWIM $6.70
- AVG Volume (30 Days)
- LIMN 611.0K
- SWIM 467.2K
- Earning Date
- LIMN 01-01-0001
- SWIM 08-05-2025
- Dividend Yield
- LIMN N/A
- SWIM N/A
- EPS Growth
- LIMN N/A
- SWIM N/A
- EPS
- LIMN N/A
- SWIM N/A
- Revenue
- LIMN N/A
- SWIM $509,311,000.00
- Revenue This Year
- LIMN N/A
- SWIM $9.24
- Revenue Next Year
- LIMN N/A
- SWIM $5.86
- P/E Ratio
- LIMN N/A
- SWIM N/A
- Revenue Growth
- LIMN N/A
- SWIM N/A
- 52 Week Low
- LIMN $4.40
- SWIM $2.54
- 52 Week High
- LIMN $33.66
- SWIM $8.41
- Technical
- Relative Strength Index (RSI)
- LIMN N/A
- SWIM 61.47
- Support Level
- LIMN N/A
- SWIM $5.75
- Resistance Level
- LIMN N/A
- SWIM $6.62
- Average True Range (ATR)
- LIMN 0.00
- SWIM 0.28
- MACD
- LIMN 0.00
- SWIM 0.07
- Stochastic Oscillator
- LIMN 0.00
- SWIM 90.82
About LIMN LIMINATUS PHARMA INC
Liminatus Pharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing cancer therapies and treatments. The GCC Vaccine of the company is in Phase II of clinical trials designed for immune behavior towards colorectal, pancreatic, gastric, and esophageal cancers that express Guanylyl Cyclase C.
About SWIM Latham Group Inc.
Latham Group Inc is a designer, manufacturer, and marketer of in-ground residential swimming pools, liners, and covers in North America, Australia, and New Zealand. It derives a majority of its revenue from the United States.